ursodiol
chemical compound
Facts
18 properties- Instance of
- type of chemical entity
- Subclass of
- sterol, bile acids
- Has use
- medication
- Canonical SMILES
- CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C
- Catalog
- CAS COVID-19 Anti-Viral Candidate Compounds
- Chemical formula
- C₂₄H₄₀O₄
- Defined daily dose
- 0.75 g
- Found in taxon
- Myocastor coypus
- Has characteristic
- bitterness
- Has part(s)
- carbon
- Isomeric SMILES
- C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C
- Mass
- 392.29266 Da
- Medical condition treated
- primary biliary cholangitis, gallstone disease, primary biliary cholangitis (1989–present)
- Melting point
- 203 °C
- Pregnancy category
- Australian pregnancy category B3, US pregnancy category B
- Stereoisomer of
- (4R)-4-[(3R,5R,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid, Allochenodeoxycholate, chenodiol, 3beta,7alpha-dihydroxy-5beta-cholan-24-oic acid, (4R)-4-[(3S,5R,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid, (4R)-4-[(3R,5S,7S,8S,9R,10S,13R,14S,17S)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid, isoursodeoxycholic acid, (4R)-4-[(3S,5R,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid, (4R)-4-[(3R,5S,7R,8S,9R,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
- Subject has role
- cholagogues and choleretics
- World Health Organisation international non-proprietary name
- ursodeoxycholic acid
🏷️ Also known as
en (3α,5β,7β)-3,7-dihydroxycholan-24-oic acid
en ursodiol
en ursodeoxycholic acid
en Urso
en UDCA
en ACG240
en (4R)-4-[(1S,2S,5R,7S,9S,10R,11S,14R,15R)-5,9-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0?,?.0??,??]heptadecan-14-yl]pentanoic acid
en 3,7-dihydroxycholan-24-oic acid
en (3a,5b,7b)-3,7-dihydroxy-cholan-24-oic acid
en (3a,5b,7b)-3,7-dihydroxycholan-24-oic acid
en 3a,7b-dihydroxy-5b-cholan-24-oic acid
en (3alpha,5beta,7beta)-3,7-dihydroxycholan-24-oic acid
en 3alpha,7beta-dihydroxy-5beta-cholan-24-oic acid
en 3-alpha,7-beta-dihydroxy-5-beta-cholanoic acid
en 3-alpha,7-beta-dihydroxycholanic acid
en 3-alpha,7-beta-dioxycholanic acid
ar حمض يوروديوكسي كوليك
cs Ursosan
cs ursodiol
cs ursodeoxycholová kyselina
🔖 Identifiers · 45
- OpenAlex ID
- C2780965833
- ATC code
- A05AA02
- CAS Registry Number
- 128-13-2
- ChEBI ID
- 9907
- ChEMBL ID
- CHEMBL1551
- ChemSpider ID
- 29131
- CosIng number
- 88849
- DSSTOX compound identifier
- DTXCID003731
- DSSTox substance ID
- DTXSID6023731
- DrugBank ID
- DB01586
- DrugCentral ID
- 2797
- EC number
- 204-879-3
Show all 45 identifiers +33
- ECHA Substance Infocard ID
- 100.004.437
- Encyclopedia of China (Third Edition) ID (2026)
- 10Fzv2
- Encyclopedia of China (Third Edition) old ID (2021)
- 449259
- Freebase ID
- /m/04vz8c
- Guide to Pharmacology Ligand ID
- 7104
- Human Metabolome Database ID
- HMDB0000946
- InChIKey
- RUDATBOHQWOJDD-UZVSRGJWSA-N
- LIPID MAPS ID
- LMST04010033
- LiverTox ID
- Ursodiol
- MassBank accession ID
- MSBNK-Metabolon-MT000012, MSBNK-Nihon_Univ-NU000136, MSBNK-Nihon_Univ-NU000137, MSBNK-Nihon_Univ-NU000138, MSBNK-Nihon_Univ-NU000139, MSBNK-Nihon_Univ-NU000140
- MeSH concept ID
- M0022413
- MeSH descriptor ID
- D014580
- MeSH tree code
- D04.210.500.105.225.272.962, D04.210.500.221.430.342.925
- MedlinePlus drug identifier
- a699047
- Microsoft Academic ID (discontinued)
- 2780965833
- NDF-RT ID
- N0000147507
- PatientsLikeMe treatment ID
- ursodiol
- Probes And Drugs ID
- PD002830
- PubChem CID
- 31401
- Reaxys registry number
- 3219888
- RxNorm CUI
- 11065
- SPLASH
- splash10-0a4i-9200000000-56bbdbde6951437dad54, splash10-0a4i-9011000000-c6002462351cd3fe7548, splash10-0006-3019200000-ea110fedbf1f6303d939, splash10-0006-1009100000-a23268ddd32187d44e91, splash10-0006-1029100010-480c93deb33afa04c9aa, splash10-00di-0009000000-7dc450000858cedb3764, splash10-00di-0009000000-42d1bd2df4c39805af9e, splash10-0006-0009000000-bdb80c6396650fd18f54, splash10-0550-0049000000-12daf2ac1ab194c58dae, splash10-0002-2911000000-eec2b269eeb08a30ac6e
- SureChEMBL ID
- 27200
- UMLS CUI
- C0042105
- UNII
- 724L30Y2QR
- UniChem compound ID
- 123080
- WikiProjectMed ID
- Ursodeoxycholic acid
- WikiSkripta article ID
- 52531
- World Health Organisation international non-proprietary name numeric ID
- 4920
- ZVG number
- 530494
🔗 Connections
Medical condition treated 3
← Drug or therapy used for treatment 3
Subclass of 2
Found in taxon 1
Has characteristic 1
Has part(s) 1
Has use 1
Stereoisomer of 1
← FactGrid item ID 1
← Stereoisomer of 1
Press Enter · cited answer in seconds
0 sources
Summary
ursodiol is a type of chemical entity[1]. ursodiol is a type of sterol[2] and bile acids[3].
Key Facts
- Canonical SMILES: CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C[4]
- Chemical formula: C₂₄H₄₀O₄[5]
- Has use: medication[6]
- Has part(s): carbon[7]
- Found in taxon: Myocastor coypus[8]
- Catalog: CAS COVID-19 Anti-Viral Candidate Compounds[9]
- Has characteristic: bitterness[10]
- Isomeric SMILES: CC@H[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C@HO)CC@H[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C@HO)C">[11]
- Mass: 392.29266 dalton[12]
- Melting point: 203 °C[13]
- Medical condition treated: primary biliary cholangitis[14], gallstone disease[15]
- World Health Organisation international non-proprietary name: ursodeoxycholic acid[16]
- Subject has role: cholagogues and choleretics[17]
- Stereoisomer of: (4R)-4-[(3R,5R,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid[18], Allochenodeoxycholate[19], chenodiol[20], 3beta,7alpha-dihydroxy-5beta-cholan-24-oic acid[21], (4R)-4-[(3S,5R,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid[22], (4R)-4-[(3R,5S,7S,8S,9R,10S,13R,14S,17S)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid[23], isoursodeoxycholic acid[24], (4R)-4-[(3S,5R,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid[25], (4R)-4-[(3R,5S,7R,8S,9R,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid[26]
- Pregnancy category: Australian pregnancy category B3[27], US pregnancy category B[28]
- Defined daily dose: 0.75 g[29]